CtrlK
Ironwood Pharmaceuticals
IRWD57
$1.51arrow_drop_down1.94%-$0.03
NASDAQ - As of Mar 14, 2:41 AM EDT Market Closed
Penny Stock
IRWD57
$1.51
arrow_drop_down1.94%| Key Stats | |
|---|---|
| Open | $1.52 |
| Prev. Close | $1.54 |
| EPS | 0.01 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $257.64M |
| PE Ratio | 151.00 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.45 | 1.57 |
| 52 Week Range | 1.34 | 15.70 |
| Fundamentals | |
|---|---|
| RPS | $1.94 |
| Gross Profit | $351.41M |
| EBITDA | $115.11M |
| Total Debt | $599.48M |
| P/S Ratio | 0.7x |
| Enterprise to EBITDA | 7.74 |
| Profit Margin | 0.52% |
| ROA | 14.81% |
| Debt/Equity Ratio | - |
| Payout Ratio | - |
| Industry average yield | 2.91% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
IRWD-
US Healthcare Sector-
US Market-
warning
IRWD / Market
IRWD lose to the US Market which returned 0.95% over the last twenty four hours.warning
IRWD / Healthcare Sector
IRWD lose to the US Healthcare sector which returned 1.88% over the last twenty four hours.Ironwood Pharmaceuticals (IRWD) Statistics
Keep an eye on Ironwood Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the EBITDA of Ironwood Pharmaceuticals (IRWD) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Ironwood Pharmaceuticals (IRWD) is $115.11M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Ironwood Pharmaceuticals (IRWD) have?
Ironwood Pharmaceuticals (IRWD) has a total debt of $599.48M. The net debt, which accounts for cash and cash equivalents against the total debt, is $526.66M.
help
How has Ironwood Pharmaceuticals (IRWD) stock's performance compared to its sector and the market over the past year?
Over the past year, Ironwood Pharmaceuticals (IRWD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.46%, Ironwood Pharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 31.78%, it has fallen short of the market average. This comparison highlights Ironwood Pharmaceuticals 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Ironwood Pharmaceuticals (IRWD) stock?
The PE (Price to Earnings) ratio of Ironwood Pharmaceuticals (IRWD) is currently 151. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Ironwood Pharmaceuticals (IRWD) stock?
The Earnings Per Share (EPS) for Ironwood Pharmaceuticals (IRWD), calculated on a diluted basis, is $0.01. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Ironwood Pharmaceuticals (IRWD) stock?
The operating margin for Ironwood Pharmaceuticals (IRWD) is 36.77%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.